Verastem (VSTM) Cash & Current Investments (2011 - 2026)
Verastem's quarterly Cash & Current Investments came in at $181.7 million in Q1 2026, up 54.53% year-on-year from $117.6 million in Q1 2025, and down 11.37% quarter-over-quarter from $205.0 million in Q4 2025.
Verastem has reported Cash & Current Investments for 16 years, with the latest figure at $181.7 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 54.53% year-over-year to $181.7 million; the trailing twelve-month figure through Mar 2026 stood at $181.7 million (up 54.53% YoY), and the FY2025 full-year result was $205.0 million, up 130.8% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $181.7 million, down from $205.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $205.0 million in Q4 2025, with the low at $83.4 million in Q2 2024.
- Average Cash & Current Investments over 5 years is $129.1 million, with a median of $113.2 million recorded in 2024.
- Year-over-year, Cash & Current Investments slumped 54.46% in 2024 and jumped 130.8% in 2025.
- Tracing VSTM's Cash & Current Investments over 5 years: stood at $92.0 million in 2022, then jumped by 48.99% to $137.1 million in 2023, then sank by 35.23% to $88.8 million in 2024, then jumped by 130.8% to $205.0 million in 2025, then retreated by 11.37% to $181.7 million in 2026.
- The last three Cash & Current Investments figures came in at $181.7 million (Q1 2026), $205.0 million (Q4 2025), and $137.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 181.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.68 Mn |
| Dec 31, 2025 | 204.99 Mn |
| Sep 30, 2025 | 137.71 Mn |
| Jun 30, 2025 | 164.32 Mn |
| Mar 31, 2025 | 117.57 Mn |
| Dec 31, 2024 | 88.82 Mn |
| Sep 30, 2024 | 113.18 Mn |
| Jun 30, 2024 | 83.37 Mn |
| Mar 31, 2024 | 110.13 Mn |
| Dec 31, 2023 | 137.13 Mn |
| Sep 30, 2023 | 165.66 Mn |
| Jun 30, 2023 | 183.09 Mn |
| Mar 31, 2023 | 111.20 Mn |
| Dec 31, 2022 | 92.04 Mn |
| Sep 30, 2022 | 103.98 Mn |
| Jun 30, 2022 | 94.31 Mn |
| Mar 31, 2022 | 106.28 Mn |
| Dec 31, 2021 | 153.80 Mn |
| Sep 30, 2021 | 103.42 Mn |
| Jun 30, 2021 | 108.14 Mn |
| Mar 31, 2021 | 121.10 Mn |
| Dec 31, 2020 | 141.23 Mn |
| Sep 30, 2020 | 170.47 Mn |
| Jun 30, 2020 | 4.89 Mn |
| Mar 31, 2020 | 135.06 Mn |
| Dec 31, 2019 | 75.51 Mn |
| Sep 30, 2019 | 160.23 Mn |
| Jun 30, 2019 | 187.25 Mn |
| Mar 31, 2019 | 211.66 Mn |
| Dec 31, 2018 | 249.65 Mn |
| Sep 30, 2018 | 145.64 Mn |
| Jun 30, 2018 | 168.69 Mn |
| Mar 31, 2018 | 64.22 Mn |
| Dec 31, 2017 | 86.67 Mn |
| Sep 30, 2017 | 60.26 Mn |
| Jun 30, 2017 | 57.92 Mn |
| Mar 31, 2017 | 72.57 Mn |
| Dec 31, 2016 | 80.90 Mn |
| Sep 30, 2016 | 86.88 Mn |
| Jun 30, 2016 | 92.87 Mn |
| Mar 31, 2016 | 99.54 Mn |
| Dec 31, 2015 | 110.26 Mn |
| Sep 30, 2015 | 120.47 Mn |
| Jun 30, 2015 | 132.09 Mn |
| Mar 31, 2015 | 132.07 Mn |
| Dec 31, 2014 | 92.68 Mn |
| Sep 30, 2014 | 93.37 Mn |
| Jun 30, 2014 | 98.60 Mn |
| Mar 31, 2014 | 105.64 Mn |
| Dec 31, 2013 | 101.31 Mn |
| Sep 30, 2013 | 99.93 Mn |
| Jun 30, 2013 | 57.45 Mn |
| Mar 31, 2013 | 66.72 Mn |
| Dec 31, 2012 | 56.58 Mn |
| Sep 30, 2012 | 46.85 Mn |
| Jun 30, 2012 | 38.69 Mn |
| Mar 31, 2012 | 41.07 Mn |
| Dec 31, 2011 | 60.76 Mn |
| Sep 30, 2011 | 41.42 Mn |
| Jun 30, 2011 | 14.16 Mn |
| Mar 31, 2011 | 2.72 Mn |